Cargando…

Cross-sectional and Test-Retest Characterization of PET with [(18)F]FP-(+)-DTBZ for β Cell Mass Estimates in Diabetes

PURPOSE: The vesicular monoamine transporter, type 2 (VMAT2) is expressed by insulin producing β cells and was evaluated as a biomarker of β cell mass (BCM) by positron emission tomography (PET) with [(18)F]fluoropropyl-dihydrotetrabenazine ([(18)F]FP-(+)-DTBZ). PROCEDURES: We evaluated the feasibil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freeby, Matthew J., Kringas, Patricia, Goland, Robin S., Leibel, Rudolph L., Maffei, Antonella, Divgi, Chaitan, Ichise, Masanori, Harris, Paul E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783444/ https://www.ncbi.nlm.nih.gov/pubmed/26370678 http://dx.doi.org/10.1007/s11307-015-0888-7

Ejemplares similares

Diagnostic value of striatal (18)F-FP-DTBZ PET in Parkinson’s disease
por: Liu, Xiu-Lin, et al.
Publicado: (2022)

Corrigendum: Diagnostic value of striatal (18)F-FP-DTBZ PET in Parkinson's disease
por: Liu, Xiu-Lin, et al.
Publicado: (2022)

Brain Imaging of Vesicular Monoamine Transporter Type 2 in Healthy Aging Subjects by (18)F-FP-(+)-DTBZ PET
por: Lin, Kun-Ju, et al.
Publicado: (2013)

PET Imaging of VMAT2 with the Novel Radioligand [(18)F]FE-DTBZ-d4 in Nonhuman Primates: Comparison with [(11)C]DTBZ and [(18)F]FE-DTBZ
por: Nag, Sangram, et al.
Publicado: (2021)

A Purification Method of (18)F-FP-(+)-DTBZ via Solid-Phase Extraction With Combined Cartridges
por: Dai, Yuyin, et al.
Publicado: (2021)

Quantitative study of (18)F-(+)DTBZ image: comparison of PET template-based and MRI based image analysis
por: Jung Lung, Hsu, et al.
Publicado: (2018)

Elucidating the Relationship Between Diabetes Mellitus and Parkinson’s Disease Using (18)F-FP-(+)-DTBZ, a Positron-Emission Tomography Probe for Vesicular Monoamine Transporter 2
por: Kong, Yanyan, et al.
Publicado: (2020)

Decreased defluorination using the novel beta-cell imaging agent [(18)F]FE-DTBZ-d4 in pigs examined by PET
por: Jahan, Mahabuba, et al.
Publicado: (2011)

PET Imaging a MPTP-Induced Mouse Model of Parkinson’s Disease Using the Fluoropropyl-Dihydrotetrabenazine Analog [(18)F]-DTBZ (AV-133)
por: Toomey, James S., et al.
Publicado: (2012)

Vesicular monoamine transporter, type 2 (vmat2) expression as it compares to insulin and pancreatic polypeptide in the head, body and tail of the human pancreas
por: Freeby, Matthew, et al.
Publicado: (2012)

Early-phase (18)F-FP-CIT and (18)F-flutemetamol PET were significantly correlated
por: An, Young-Sil, et al.
Publicado: (2021)

A Case of Genetically Confirmed Chorea-Acanthocytosis: Brain [(18)F]FDG-PET and [(18)F]FP-CIT-PET Findings
por: Lee, Jong-Mok, et al.
Publicado: (2020)

Diagnostic accuracy of (18)F-FP-CIT PET for clinically uncertain Parkinsonian syndrome
por: Oh, Minyoung, et al.
Publicado: (2023)

Differential Diagnosis of Patients with Inconclusive Parkinsonian Features Using [(18)F]FP-CIT PET/CT
por: Park, Eunkyung, et al.
Publicado: (2013)

F-18 FP-CIT PET in Multiple System Atrophy of the Cerebellar Type: Additional Role in Treatment
por: Jeong, Young Jin, et al.
Publicado: (2017)

Salivary Gland Uptake on (18)F-FP-CIT PET as a New Biomarker in Patients With Parkinsonism
por: Kang, Seo Young, et al.
Publicado: (2023)

Test–retest repeatability of [(18)F]Flortaucipir PET in Alzheimer’s disease and cognitively normal individuals
por: Timmers, Tessa, et al.
Publicado: (2019)

Comparison of perfusion (18)F-FP-CIT PET and (99m)Tc-ECD SPECT in parkinsonian disorders
por: Chun, KyungAh, et al.
Publicado: (2021)

Diagnostic accuracy of dual-phase (18)F-FP-CIT PET imaging for detection and differential diagnosis of Parkinsonism
por: Oh, Minyoung, et al.
Publicado: (2021)

Differential diagnosis of patients with atypical Parkinsonian syndrome using (18)F-FDG and (18)F-FP CIT PET: A report of five cases
por: Yoo, Jang, et al.
Publicado: (2022)

Heterogeneity by global and textural feature analysis in F-18 FP-CIT brain PET images for diagnosis of Parkinson's disease
por: Yoon, Hyun Jin, et al.
Publicado: (2021)

Dual phase (18)F-FP CIT PET and (99m)Tc- ECD SPECT findings of Huntington's disease()
por: Chun, KyungAh
Publicado: (2022)

β-Cell Dysfunction Due to Increased ER Stress in a Stem Cell Model of Wolfram Syndrome
por: Shang, Linshan, et al.
Publicado: (2014)

18F-FP-CIT PET/CT in a case of probable sporadic Creutzfeldt-Jakob disease with parkinsonism as initial symptom
por: Tang, Songhan, et al.
Publicado: (2022)

Awake (18)F-FDG PET Imaging of Memantine-Induced Brain Activation and Test–Retest in Freely Running Mice
por: Miranda, Alan, et al.
Publicado: (2019)

Test–Retest Repeatability of [(18)F]MC225-PET in Rodents: A Tracer for Imaging of P-gp Function
por: García-Varela, Lara, et al.
Publicado: (2020)

Simple, Rapid and Reliable Preparation of [(11)C]-(+)-α-DTBZ of High Quality for Routine Applications
por: Zhang, Jinming, et al.
Publicado: (2012)

Effects of rigid and non-rigid image registration on test-retest variability of quantitative [(18)F]FDG PET/CT studies
por: van Velden, Floris HP, et al.
Publicado: (2012)

Dopamine transporter imaging with [(18)F]FE-PE2I PET and [(123)I]FP-CIT SPECT—a clinical comparison
por: Jakobson Mo, Susanna, et al.
Publicado: (2018)

Comparative test-retest variability of outcome parameters derived from brain [(18)F]FDG PET studies in non-human primates
por: Goutal, Sébastien, et al.
Publicado: (2020)

PET imaging of beta-secretase 1 in the human brain: radiation dosimetry, quantification, and test-retest examination of [(18)F]PF-06684511
por: Arakawa, Ryosuke, et al.
Publicado: (2020)

Usefulness of F-18 FP-CIT PET to predict dopamine-responsive hand tremor in patients other than Parkinson's disease: Two case reports
por: Yu, Kwang Jae, et al.
Publicado: (2018)

Diagnostic Performance for Differential Diagnosis of Atypical Parkinsonian Syndromes from Parkinson’s Disease Using Quantitative Indices of (18)F-FP-CIT PET/CT
por: Cheon, Miju, et al.
Publicado: (2022)

18F-FP-CIT Positron Emission Tomography for Correlating Motor and Cognitive Symptoms of Parkinson's Disease
por: Yang, YoungSoon, et al.
Publicado: (2017)

Quantification of [(18)F]florbetapir: A test–retest tracer kinetic modelling study
por: Golla, Sandeep SV, et al.
Publicado: (2018)

(18)F-FP-PEG(2)-β-Glu-RGD(2): A Symmetric Integrin α(v)β(3)-Targeting Radiotracer for Tumor PET Imaging
por: Hu, Kongzhen, et al.
Publicado: (2015)

[(18)F]FE-PE2I PET is a feasible alternative to [(123)I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
por: Marner, Lisbeth, et al.
Publicado: (2022)

Validation, kinetic modeling, and test-retest reproducibility of [(18)F]SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2A in mice
por: Bertoglio, Daniele, et al.
Publicado: (2022)

Comparison of [(18)F]-FDOPA PET and [(123)I]-FP-CIT SPECT acquired in clinical practice for assessing nigrostriatal degeneration in patients with a clinically uncertain parkinsonian syndrome
por: Wallert, Elon, et al.
Publicado: (2022)

Correction: [(18)F]FE-PE2I PET is a feasible alternative to [(123)I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
por: Marner, Lisbeth, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mcbuahpdd56vl0qb6btk0j8403